• PharmaKure Announces Epigenetics Collaboration with Sheffield Hallam University to Underst... 3/1/2024
• PharmaKure Submits MHRA CTA for Phase 2a Clinical Trial of PK051 in Patients with Mild Cog... 10/31/2023
• PharmaKure Announces Study Success for Novel Blood Test to Identify Biomarkers in Patients... 10/23/2023